Literature DB >> 20197776

Vasculitis syndromes: Inducing remission in ANCA-positive vasculitis: time to RAVE?

Richard A Watts.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20197776     DOI： 10.1038/nrrheum.2010.19

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  7 in total

Review 1.  Rituximab and Wegener's granulomatosis: are B cells a target in vasculitis treatment?

Authors:  Michael C Sneller
Journal:  Arthritis Rheum       Date:  2005-01

2.  EULAR recommendations for the management of primary small and medium vessel vasculitis.

Authors:  C Mukhtyar; L Guillevin; M C Cid; B Dasgupta; K de Groot; W Gross; T Hauser; B Hellmich; D Jayne; C G M Kallenberg; P A Merkel; H Raspe; C Salvarani; D G I Scott; C Stegeman; R Watts; K Westman; J Witter; H Yazici; R Luqmani
Journal:  Ann Rheum Dis       Date:  2008-04-15       Impact factor: 19.103

3.  Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Kirsten De Groot; Niels Rasmussen; Paul A Bacon; Jan Willem Cohen Tervaert; Conleth Feighery; Gina Gregorini; Wolfgang L Gross; Raashid Luqmani; David R W Jayne
Journal:  Arthritis Rheum       Date:  2005-08

4.  A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies.

Authors:  David Jayne; Niels Rasmussen; Konrad Andrassy; Paul Bacon; Jan Willem Cohen Tervaert; Jolanta Dadoniené; Agneta Ekstrand; Gill Gaskin; Gina Gregorini; Kirsten de Groot; Wolfgang Gross; E Christiaan Hagen; Eduardo Mirapeix; Erna Pettersson; Carl Siegert; Alberto Sinico; Vladimir Tesar; Kerstin Westman; Charles Pusey
Journal:  N Engl J Med       Date:  2003-07-03       Impact factor: 91.245

Review 5.  Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies.

Authors:  Eugene O Major
Journal:  Annu Rev Med       Date:  2010       Impact factor: 13.739

6.  Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial.

Authors:  Kirsten de Groot; Lorraine Harper; David R W Jayne; Luis Felipe Flores Suarez; Gina Gregorini; Wolfgang L Gross; Rashid Luqmani; Charles D Pusey; Niels Rasmussen; Renato A Sinico; Vladimir Tesar; Philippe Vanhille; Kerstin Westman; Caroline O S Savage
Journal:  Ann Intern Med       Date:  2009-05-19       Impact factor: 25.391

Review 7.  Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials.

Authors:  C Salliot; M Dougados; L Gossec
Journal:  Ann Rheum Dis       Date:  2008-01-18       Impact factor: 19.103
  7 in total
  1 in total

1.  Anti-cytokine targeted therapies for ANCA-associated vasculitis.

Authors:  Malgorzata M Bala; Teresa J Malecka-Massalska; Magdalena Koperny; Joanna F Zajac; Jarosław D Jarczewski; Wojciech Szczeklik
Journal:  Cochrane Database Syst Rev       Date:  2020-09-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.